Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/06/1995 | US5422366 Forming oxygen-scavenging metal chelate or metal complex-containing film over nail to deprive aerobic fungi of oxygen |
06/06/1995 | US5422363 Therapy of cancer, diabetes and vision disorders |
06/06/1995 | US5422362 Method to inhibit restenosis |
06/06/1995 | US5422361 Stable cream and lotion bases for lipophilic drug compositions |
06/06/1995 | US5422347 Fungicides, hair and skin disorders |
06/06/1995 | US5422261 Pure, aqueous, nontoxic mixtures of proteolytic enzymes in buffered physiologically compatible electrolyte solutions |
06/06/1995 | US5422136 Starch-based food enhancing ingredient |
06/06/1995 | US5422124 Pharmaceutical oral controlled release composition comprising small pellets of bile acids |
06/06/1995 | US5422123 Comprising a core of drug, swellable polymer and gellable polymer and a cover or support of swellable and gellable polymers; noncracking and -flaking |
06/06/1995 | US5422122 Controlled release potassium chloride tablet |
06/06/1995 | US5422121 Decompsable polysaccharide shell surrounding drug with film-forming cationic acrylic polymer |
06/06/1995 | US5422120 Two substances encapsulated in separaqte chambers |
06/06/1995 | US5422118 Transdermal administration of amines with minimal irritation and high transdermal flux rate |
06/06/1995 | US5422117 Multiphase pharmaceutical formulations |
06/06/1995 | US5422116 Administering to eye homogeneous liquid aqueous composition containing chitosan as release rate controlling agent |
06/06/1995 | US5422115 Methods of treatment and devices employing lithium salts |
06/06/1995 | US5422114 Compositions of iodoaniline derivatives and cellulose derivatives for visualization of the gastrointestinal tract |
06/06/1995 | US5422109 Fluid vaccines and active principle vehicles containing a metabolizable oil |
06/06/1995 | US5422103 Wound healing agents for burns, bed sores; blended with dextran |
06/06/1995 | US5422102 Diclofenac or salt with nonionic polymer of hydroxypropyl and/or hydroxyethyl cellulose; percutaneous adsorption |
06/06/1995 | CA2044795C Dermatological composition based on an aqueous phase |
06/06/1995 | CA1335858C Polyanhydrides with improved hydrolytic degradation properties |
06/06/1995 | CA1335804C Method for modifying the surface of a polymer |
06/06/1995 | CA1335789C Fatty acid compositions |
06/01/1995 | WO1995014785A1 Composition for the in vivo production of therapeutic products |
06/01/1995 | WO1995014651A1 Amphiphilic derivatives of piperazine |
06/01/1995 | WO1995014531A1 Particles for binding monovalent cations, use of such particles as well as methods for scavenging and removing sodium and/or potassium ions |
06/01/1995 | WO1995014486A1 Medicinal activity of aspartame |
06/01/1995 | WO1995014480A1 Composition for curing lesioned tissue, process for producing the same, and use thereof |
06/01/1995 | WO1995014462A1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
06/01/1995 | WO1995014460A1 Opioid formulations for treating pain |
06/01/1995 | WO1995014459A1 Liposomes for the encapsulation of doxorubicine |
06/01/1995 | WO1995014381A1 Amphiphilic derivatives of guanidine |
06/01/1995 | WO1995014380A1 Amphiphilic imidazolinium derivatives |
06/01/1995 | DE4340366A1 Use of urea adducts of fatty acids |
06/01/1995 | DE4339985A1 Pharmaceutical compsn. contg. di:halo-quinoline deriv. |
06/01/1995 | CA2177466A1 Particles for binding monovalent cations, use of such particles as well as methods for scavenging and removing sodium and/or potassium ions |
06/01/1995 | CA2177075A1 Medicinal activity of aspartame |
06/01/1995 | CA2176715A1 Amphiphilic derivatives of guanidine |
06/01/1995 | CA2176714A1 Amphiphilic derivatives of piperazine |
05/31/1995 | EP0655241A1 Soft gelatine capsule containing a mixture with a high water content |
05/31/1995 | EP0655240A2 Immediate release tablet cores of insoluble drugs having substained-release coating |
05/31/1995 | EP0655239A1 Liposomes encapsulating doxorubicine |
05/31/1995 | EP0655238A1 Process for preparing liposomes by enzymatic way |
05/31/1995 | EP0655237A1 Medicinal aerosol formulation |
05/31/1995 | EP0655069A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
05/31/1995 | EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
05/31/1995 | EP0654992A1 Method for treatment and prevention of irritable bowel syndrome and pharmaceutical compositions therefor |
05/31/1995 | EP0553281B1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
05/31/1995 | CN2198921Y Adhesive plaster for promoting blood circulation and stopping pain |
05/31/1995 | CN1103234A Taste modifying method and bitter taste reducing method |
05/31/1995 | CN1103098A Polyurethane pressure-sensitive adhesives |
05/31/1995 | CN1102981A Ferric selenium injection for animal |
05/31/1995 | CA2137025A1 Liquid preparations containing cyclosporin and process for preparing same |
05/30/1995 | USRE34958 Polysiloxane-grafted copolymer topical binder composition with novel hydrophilic monomers and method of coating therewith |
05/30/1995 | US5420359 Blood substitutes, solvents |
05/30/1995 | US5420197 Wound and burn dressings, cosmetic applications, drug delivery |
05/30/1995 | US5420152 Melatonin |
05/30/1995 | US5420124 Stable, painless piroxicam potassium injectable composition |
05/30/1995 | US5420106 Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
05/30/1995 | US5419918 Method for the manufacture of a controlled release solid unit dosage form |
05/30/1995 | US5419917 Controlled release hydrogel formulation |
05/30/1995 | US5419916 Gelatin coating composition and hard gelatin capsule |
05/30/1995 | US5419915 Medicament with an analgesic, antipyretic and/or antiphlogistic action and use of 2-ethoxybenzoic acid |
05/30/1995 | US5419914 Phospholipid analogue vesicle |
05/30/1995 | US5419913 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like |
05/30/1995 | US5419912 Adhesive patch for percutaneous delivery of isosorbide dinitrate |
05/30/1995 | US5419910 Growth promoters for animals |
05/30/1995 | US5419898 Antiallergic composition for ophthalmic or nasal use |
05/30/1995 | US5419760 Medicament dispensing stent for prevention of restenosis of a blood vessel |
05/30/1995 | US5419315 Intrapulmonary delivery of hormones |
05/30/1995 | CA1335715C In vivo delivery of neurotransmitters by implanted, encapsulated cells |
05/30/1995 | CA1335714C Fluorocarbon emulsions having saturated phospholipid emulsifiers |
05/30/1995 | CA1335711C Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases |
05/28/1995 | CA2136704A1 Medicinal aerosol formulation |
05/26/1995 | WO1995014037A1 Transparent liquid for encapsulated drug delivery |
05/26/1995 | WO1995013863A1 Alkylglycoside-containing concentrate and uses thereof |
05/26/1995 | WO1995013843A1 Method and apparatus for delivering oxygen into blood |
05/26/1995 | WO1995013825A1 TRANSDERMAL COMPOSITION OF N-[N-[5-[4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-α-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
05/26/1995 | WO1995013816A1 Transdermal prostaglandin composition |
05/26/1995 | WO1995013814A1 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
05/26/1995 | WO1995013810A1 Nasal spray compositions containing oxymetazoline |
05/26/1995 | WO1995013806A1 Compositions containing zinc linoleate for the treatment of skin disorders |
05/26/1995 | WO1995013799A1 Preparation of biodegradable microparticles containing a biologically active agent |
05/26/1995 | WO1995013798A1 Controlled release preparation |
05/26/1995 | WO1995013797A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
05/26/1995 | WO1995013796A1 Vesicles with controlled release of actives |
05/26/1995 | WO1995013795A1 Hydrophobic preparations |
05/26/1995 | WO1995013794A1 Process for producing stable medicinal composition, and pharmaceutical preparation |
05/26/1995 | WO1995013787A2 Cold-water emulsifiable agents |
05/26/1995 | WO1995013765A1 Biocompatible ocular implants |
05/26/1995 | CA2176933A1 Controlled release preparation |
05/26/1995 | CA2176601A1 Method and apparatus for delivering oxygen into blood |
05/26/1995 | CA2176577A1 Hydrophobic preparations |
05/26/1995 | CA2176462A1 Transdermal composition of n-¬n-¬5-¬4-(aminoiminomethyl)phenyl|-1-oxopentyl|-l-.alpha.-aspartyl|-l-phenylalanine or its esters and their pharmaceutically acceptable salts |
05/26/1995 | CA2175350A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
05/26/1995 | CA2109989A1 Polymerized collagen-based anti-fibroid composition |
05/25/1995 | CA2109895A1 Nicotine containing oral preparation |
05/24/1995 | EP0654484A2 Pharmaceutical compositions containing inclusion compounds of thioctic or dihydroliponic acid with cyclodextrins and in granule form or in chewable or effervescent tablet form |
05/24/1995 | EP0654263A1 Sustained release composition and a method of preparing pharmaceutical compositions |